Study summary · 2023 · Observational
CCM and diabetes-related service use in Louisiana
Overall CCM was associated with fewer acute encounters, but some subgroup and complication outcomes were unchanged or worse.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Yixue Shao; Charles Stoecker; Dongzhe Hong; Elizabeth Nauman; Vivian Fonseca; Gang Hu; Alessandra N Bazzano; Edmond K Kabagambe; Lizheng Shi
Tulane University; Louisiana Public Health Institute; Pennington Biomedical Research Center; Ochsner Health.
Value in Health · Online: · Issue: May 2023
Final 2023 issue article, online 2022; accessible accepted manuscript. · Full text consulted.
What was studied
- Design
- Observational
- Population
- Patients with type 2 diabetes and Medicare as primary payer in three health systems.
- Sample
- 22,242 patients: 1,668 CCM recipients and 20,574 nonrecipients.
- Intervention
- Billed non-face-to-face CCM.
- Comparator
- Patients without CCM, balanced using prior trajectories and propensity scores.
- Follow-up
- 24 months after initial CCM; records from 2013 to early 2020.
- Setting
- Louisiana, USA
Methods
Quasi-experimental analysis of electronic health records.
Findings
Per 1,000 patients monthly, adjusted associations were 657 more outpatient visits (95% CI 626–687), 5 fewer admissions (2–7), and 4 fewer ED visits (1–7). Complex CCM separately was associated with 13 more ED visits per 1,000 patients monthly (95% CI 9–17); several complication endpoints were unchanged or worse.
Limitations
Nonrandom participation and regional EHR coverage permit confounding and incomplete encounter capture. The related Hong claims analysis uses overlapping Louisiana years; unknown patient overlap prevents treating it as an independent replication.
What this means for care delivery
Outpatient workload belongs alongside acute-care outcomes in a CCM evaluation.